Narcisa Mesaros | VP, Medical Science & Strategy
PPD clinical research business of Thermo Fisher Scientific

Narcisa Mesaros, MD, is the Vice President of the Medical Science & Strategy group at PPD, the clinical research business of Thermo Fisher Scientific. She joined PPD from Janssen where she worked as the Clinical Franchise Leader for bacterial vaccines portfolio. Prior, Narcisa spent 15 years at GSK working in positions of increasing responsibility. Narcisa has supported the clinical development of a broad range of vaccines against bacterial and viral pathogens including RSV, COVID-19, and bacterial meningitis. In addition, Narcisa has led the development of combination vaccination products as well as therapeutic vaccine development in oncology. Narcisa has extensive experience with vaccine program design and regulatory interactions, including submission activities, managing key opinion leader (KOL) advisory boards, and independent data monitoring committees (IDMCs).